LPO, CFD, CPNE8, HTR1F, and MPO showed noticeably higher expression in the AML sample than in the normal sample, while LSPl, PLXNCI and BCL2A1 showed decreased expression (Figure 6). The gene discussed is BCL2A1; the disease is acute myeloid leukemia.